[{"id":"b6dca039-ae2d-4e16-87dc-6e74f95f97fb","acronym":"","url":"https://clinicaltrials.gov/study/NCT02516553","created_at":"2021-01-18T12:09:36.817Z","updated_at":"2024-07-02T16:35:09.784Z","phase":"Phase 1","brief_title":"BI 894999 First in Human Dose Finding Study in Advanced Malignancies","source_id_and_acronym":"NCT02516553","lead_sponsor":"Boehringer Ingelheim","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e amredobresib (BI 894999)"],"overall_status":"Completed","enrollment":" Enrollment 174","initiation":"Initiation: 07/08/2015","start_date":" 07/08/2015","primary_txt":" Primary completion: 11/23/2021","primary_completion_date":" 11/23/2021","study_txt":" Completion: 11/23/2021","study_completion_date":" 11/23/2021","last_update_posted":"2024-04-15"}]